MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Tremors: Treatment"

  • 2019 International Congress

    The STN Sweet Spot for Tremor Control in Parkinson’s Disease

    T. Stiep, A. Diaz, I. Cajigas, J. Jagid, C. Luca (Miami, FL, USA)

    Objective: Describe 4 cases of Parkinson’s disease (PD) patients with residual tremor post deep brain stimulation of subthalamic nucleus (DBS-STN) that underwent repositioning of electrodes…
  • 2019 International Congress

    Is directional stimulation of the VIM superior to omnidirectional stimulation in patients with essential tremor?

    S. Fliegen, P. Nikolov, C. Hartmann, P. Slotty, J. Vesper, A. Schnitzler, S. Groiß (Düsseldorf, Germany)

    Objective: To determine whether directional stimulation of the VIM is superior to omnidirectional stimulation in essential tremor. Background: Deep brain stimulation (DBS) of the VIM…
  • 2019 International Congress

    Resting-State fMRI in Essential Tremor after MRgFUS treatment

    C. Kindler, V. Purrer, N. Upadhyay, V. Keil, V. Borger, C. Pieper, L. Scheef, H. Boecker, U. Wuellner (Bonn, Germany)

    Objective: Identify network alterations in essential tremor (ET) after magnetic resonance–guided focused ultrasound (MRgFUS) treatment using independent component analysis (ICA). Background: MRgFUS has been approved…
  • 2019 International Congress

    Improvement of lower extremity Holmes tremor with intrathecal baclofen: First Report

    S. Saad, C. Kilbane, H. Abboud (Cleveland, OH, USA)

    Objective: OBJECTIVE: To describe a novel response of Atypical Holmes tremor to intrathecal baclofen (ITB). Background: Holmes tremor is a rare low-frequency high-amplitude tremor predominantly…
  • 2019 International Congress

    Efficacy of Stereotactic lesioning in Multi-etiological tremor

    D. Srinivas, R. Yadav, P. Pal (Bangalore, India)

    Objective: Analyse our experience with Stereotactic lesioning for  multi-etiological tremor. Background: Lesioning in tremor had been one of the most widely used procedures before the…
  • 2019 International Congress

    The concept of a ‘long lesion’ in thalamic/Zona inserta DBS for MS tremor suppression

    S. Alusi, B. Hammersley, J. Somerset, P. Eldridge, J. Farah (Liverpool, United Kingdom)

    Objective: To look at whether DBS programming to create a long field of stimulation in the thalamus-zona inserta (ZI) area is more effective, than traditional…
  • 2019 International Congress

    Deep brain stimulation of Caudal Zona incerta: Case series

    DR. Ginjupally, Z. Guduru, T. Hines Iii, T. Ali, G. Quintero, C. van Horne (Lexington, KY, USA)

    Objective: With the advancement of deep brain stimulation (DBS) techniques, a renewed interest in the posterior sub thalamic area (PSA) for the treatment of Parkinson's…
  • 2019 International Congress

    VIM stimulation for refractory tremor -the Sheba experience

    V. Livneh, S. Korn, G. Yaalom, T. Karmon, H. Strauss, Z. Zibly, R. Spiegelmann, S. Baer (Tel Aviv, Israel)

    Objective: This study describes our center's experience with 26 patients who underwent surgery for thalamic ventral intermediate nucleus (VIM) stimulation between years 2008-2018 Background: Deep-brain…
  • 2019 International Congress

    Compression Therapy: A Treatment of Rubral Tremor

    D. Nacopoulos (Erie, PA, USA)

    Objective: To present a case of a post-stroke rubral tremor which benefited from compression therapy to the affected arm, improving medication-refractory tremor. Background: Rubral and ataxic…
  • 2019 International Congress

    GABA-A Receptor Positive Allosteric Modulators: Phase 2 Proof of Concept Studies of Brexanolone Injection and SAGE-217 in Essential Tremor

    J. Paskavitz, A. Bullock, D. Nguyen, A. Smith, B. Farley, M. Quirk, I. Kaul, S. Li, A. Ellenbogen, C. Silber, J. Doherty, H. Colquhoun, S. Kanes (Cambridge, MA, USA)

    Objective: To examine use of γ-aminobutyric acid (GABA) type A receptor (GABA-A-R) positive allosteric modulators (PAMs) in the treatment of essential tremor (ET) in early…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 17
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley